Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study

NCT05746039 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05746039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study
Lead sponsor
University of Pennsylvania
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 29, 2024
Completion date
December 28, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, interstitial lung disease, obesity, pulmonary hypertension, sarcoidosis, pulmonary